-
平臺編號：bio-68953
-
國際編號：HB-8210?
-
細胞信息： 2AB1-IA10
-
規(guī)格：frozen
-
用途：ATCC原裝細胞
-
服務費用：
加載中…… - 訂購
-
注意事項：僅用于科學研究或者工業(yè)應用等非醫(yī)療目的不可用于人類或動物的臨床診斷或治療，非藥用，非食用（產(chǎn)品信息以出庫為準）
2AB1-IA10
生長狀態(tài)：懸浮生長
數(shù)量：大量
細胞形態(tài)：淋巴樣
免疫類型：IgG2b
是否是腫瘤細胞：0
物種來源：大鼠
ATCC Number：HB-8210?
運輸方式：凍存運輸
規(guī)格：0.5mg Designations: 2AB1-IA10
Depositors: ?University of Pittsburgh
Isotype: IgG2b
Biosafety Level:1
Shipped: frozen
Medium & Serum: See Propagation Growth Properties:suspension
Organism: Rattus norvegicus (B cell); Mus musculus (myeloma) deposited as rat (B cell); mouse (myeloma)
Morphology:lymphoblast
Source: Cell Type: hybridoma: B lymphocyte;
Cellular Products:immunoglobulin; monoclonal antibody; against laminin (basement membrane glycoprotein)
Permits/Forms:In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Comments:Animals were immunized with extracellular matrix proteins from M1536-B3 cells.
Spleen cells were fused with Sp2/0-Ag14 myeloma cells.
The antibody reacts with laminin and can be used to detect laminin in tissues, and for isolation and quantitation of laminin.
Propagation: ATCC complete growth medium: Alpha minimum essential medium, 90%; heat-inactivated horse serum, 10%
Subculturing: Medium Renewal: Every 2 to 3 days
Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml.
References: 3880: Chung AE. Novel hybridoma cell line producing monoclonal antibodies against laminin and a process for the production thereof. US Patent 4,642,293 dated Feb 10 1987
數(shù)量：大量
細胞形態(tài)：淋巴樣
免疫類型：IgG2b
是否是腫瘤細胞：0
物種來源：大鼠
ATCC Number：HB-8210?
運輸方式：凍存運輸
規(guī)格：0.5mg Designations: 2AB1-IA10
Depositors: ?University of Pittsburgh
Isotype: IgG2b
Biosafety Level:1
Shipped: frozen
Medium & Serum: See Propagation Growth Properties:suspension
Organism: Rattus norvegicus (B cell); Mus musculus (myeloma) deposited as rat (B cell); mouse (myeloma)
Morphology:lymphoblast
Source: Cell Type: hybridoma: B lymphocyte;
Cellular Products:immunoglobulin; monoclonal antibody; against laminin (basement membrane glycoprotein)
Permits/Forms:In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Comments:Animals were immunized with extracellular matrix proteins from M1536-B3 cells.
Spleen cells were fused with Sp2/0-Ag14 myeloma cells.
The antibody reacts with laminin and can be used to detect laminin in tissues, and for isolation and quantitation of laminin.
Propagation: ATCC complete growth medium: Alpha minimum essential medium, 90%; heat-inactivated horse serum, 10%
Subculturing: Medium Renewal: Every 2 to 3 days
Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml.
References: 3880: Chung AE. Novel hybridoma cell line producing monoclonal antibodies against laminin and a process for the production thereof. US Patent 4,642,293 dated Feb 10 1987
